Randomized trial of anakinra in heart failure shows increased IL-1Ra levels versus placebo over 24 weeks
Heart Failure Drug Boosts Natural Inflammation Blockers in Blood
This randomized trial abstract reports on-treatment plasma IL-1Ra levels in 63 patients with heart failure and reduced ejection fraction (HF…
A new heart failure drug significantly increases natural inflammation blockers in the blood to fight silent fires.
Anakinra reduces inflammatory markers in prediabetes but shows no metabolic improvements in RCT
Two anakinra injections changed blood markers in people with prediabetes
A randomized controlled trial in individuals with prediabetes found that two injections of anakinra significantly reduced total leucocyte co…
Two anakinra injections quickly lowered inflammation markers in people with prediabetes, though the drug did not yet improve blood sugar con…